Literature DB >> 9654265

Rhabdomyolysis due to interaction of simvastatin with mibefradil.

D Schmassmann-Suhijar, R Bullingham, R Gasser, J Schmutz, W E Haefeli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9654265     DOI： 10.1016/S0140-6736(05)78613-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

Review 1.  Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?

Authors:  Jennifer Martin; Henry Krum
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  ADME of biologics-what have we learned from small molecules?

Authors:  Thomayant Prueksaritanont; Cuyue Tang
Journal:  AAPS J       Date:  2012-04-07       Impact factor: 4.009

3.  Objective assessment of nonadherence and unknown co-medication in hospitalized patients.

Authors:  Florentine Carow; Karin Rieger; Ingeborg Walter-Sack; Markus R Meyer; Frank T Peters; Hans H Maurer; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2012-02-22       Impact factor: 2.953

4.  Successful strategy to improve the specificity of electronic statin-drug interaction alerts.

Authors:  Hanna Marita Seidling; Caroline Henrike Storch; Thilo Bertsche; Christian Senger; Jens Kaltschmidt; Ingeborg Walter-Sack; Walter Emil Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2009-07-30       Impact factor: 2.953

5.  Transporters in drug development: advancing on the Critical Path.

Authors:  Shiew-Mei Huang; Janet Woodcock
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 6.  Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

Authors:  Carl J Fichtenbaum; John G Gerber
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 8.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients.

Authors:  K R Yeo; W W Yeo; E J Wallis; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 10.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.